关注
Leonardo Iaccarino
Leonardo Iaccarino
Eli Lilly and Company, Avid
在 lilly.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration
EH Thijssen, R La Joie, A Wolf, A Strom, P Wang, L Iaccarino, ...
Nature medicine 26 (3), 387-397, 2020
5552020
Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET
R La Joie, AV Visani, SL Baker, JA Brown, V Bourakova, J Cha, ...
Science Translational Medicine 12 (524), 2020
4512020
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study
EH Thijssen, R La Joie, A Strom, C Fonseca, L Iaccarino, A Wolf, S Spina, ...
The Lancet Neurology 20 (9), 739-752, 2021
2792021
Targeting neuroinflammation to treat Alzheimer’s disease
A Ardura-Fabregat, E Boddeke, A Boza-Serrano, S Brioschi, ...
CNS drugs 31 (12), 1057-1082, 2017
2432017
Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia
MA Santos-Santos, GD Rabinovici, L Iaccarino, N Ayakta, G Tammewar, ...
JAMA neurology 75 (3), 342-352, 2018
221*2018
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission …
R Ossenkoppele, R Smith, N Mattsson-Carlgren, C Groot, A Leuzy, ...
JAMA neurology 78 (8), 961-971, 2021
1862021
Local and distant relationships between amyloid, tau and neurodegeneration in Alzheimer's Disease
L Iaccarino, G Tammewar, N Ayakta, SL Baker, A Bejanin, AL Boxer, ...
NeuroImage: Clinical 17, 452-464, 2018
1652018
18F-flortaucipir PET to autopsy comparisons in Alzheimer’s disease and other neurodegenerative diseases
DN Soleimani-Meigooni, L Iaccarino, R La Joie, S Baker, V Bourakova, ...
Brain 143 (11), 3477-3494, 2020
1132020
Association of APOE4 and clinical variability in Alzheimer disease with the pattern of tau-and amyloid-PET
R La Joie, AV Visani, OH Lesman-Segev, SL Baker, L Edwards, ...
Neurology 96 (5), e650-e661, 2021
882021
Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging
C Cerami, L Iaccarino, D Perani
International Journal of Molecular Sciences 18 (5), 993, 2017
862017
Association between ambient air pollution and amyloid positron emission tomography positivity in older adults with cognitive impairment
L Iaccarino, R La Joie, OH Lesman-Segev, E Lee, L Hanna, IE Allen, ...
JAMA neurology 78 (2), 197-207, 2021
832021
Tau covariance patterns in Alzheimer's disease patients match intrinsic connectivity networks in the healthy brain
R Ossenkoppele, L Iaccarino, DR Schonhaut, JA Brown, R La Joie, ...
NeuroImage: Clinical 23, 101848, 2019
832019
A Survey of FDG-and Amyloid-PET Imaging in Dementia and GRADE Analysis
D Perani, O Schillaci, A Padovani, FM Nobili, L Iaccarino, PA Della Rosa, ...
BioMed Research International 2014, 2014
78*2014
Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria
SP Caminiti, A Sala, L Iaccarino, L Beretta, A Pilotto, L Gianolli, ...
Alzheimer's research & therapy 11, 1-14, 2019
752019
Neurophysiological signatures in Alzheimer’s disease are distinctly associated with TAU, amyloid-β accumulation, and cognitive decline
KG Ranasinghe, J Cha, L Iaccarino, LB Hinkley, AJ Beagle, J Pham, ...
Science Translational Medicine 12 (534), 2020
742020
Neuropsychiatric subsyndromes and brain metabolic network dysfunctions in early onset Alzheimer's disease
T Ballarini, L Iaccarino, G Magnani, N Ayakta, BL Miller, WJ Jagust, ...
Human Brain Mapping, 2016
722016
Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) investigators. Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and …
EH Thijssen, R La Joie, A Wolf, A Strom, P Wang, L Iaccarino, ...
Nat Med 26 (3), 387-397, 2020
712020
A Cross-Validation of FDG-and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer’s Disease in a Clinical Setting
L Iaccarino, K Chiotis, P Alongi, O Almkvist, A Wall, C Cerami, V Bettinardi, ...
Journal of Alzheimer's Disease, 1-12, 2017
692017
Cerebrospinal Fluid Biomarkers in Autopsy-Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration
N Mattsson-Carlgren, LT Grinberg, A Boxer, R Ossenkoppele, M Jonsson, ...
Neurology, 2022
662022
The semantic variant of primary progressive aphasia: clinical and neuroimaging evidence in single subjects.
L Iaccarino, C Crespi, PA Della Rosa, E Catricalà, L Guidi, A Marcone, ...
PloS one 10 (3), e0120197, 2015
622015
系统目前无法执行此操作,请稍后再试。
文章 1–20